Frequently Asked Questions About Glp 1
What are GLP‑1 medications and how do they work for weight loss?
GLP‑1 (glucagon-like peptide‑1) medications are prescription drugs that mimic the natural GLP‑1 hormone your body releases after eating. This hormone helps regulate blood sugar, insulin, and appetite. GLP‑1 receptor agonists (such as semaglutide and liraglutide) activate GLP‑1 receptors in the brain and gut to:
- Slow stomach emptying, so you feel full longer
- Reduce appetite and food cravings
- Increase insulin release when blood sugar is high
- Decrease glucagon (a hormone that raises blood sugar)
Clinical trials show that GLP‑1 medications like semaglutide can lead to significant weight loss when combined with diet and exercise, with some patients losing around 10–15% of their body weight over time in large randomized trials. They were originally developed for type 2 diabetes and later approved for chronic weight management in certain patients.
Who is a good candidate for GLP‑1 weight‑loss treatment?
You may be a candidate if you:
- Have a BMI ≥30 (obesity), or
- Have a BMI ≥27 with at least one weight‑related condition (such as hypertension, high cholesterol, or type 2 diabetes), as outlined in FDA prescribing information
- Have tried lifestyle changes (diet, exercise, behavior modification) without sufficient success
- Do not have contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), or a history of serious hypersensitivity to the medication
A healthcare provider will review your medical history, current medications, and lab work to determine if GLP‑1 therapy is appropriate and safe for you.
What are the common treatment areas for GLP‑1 medications?
GLP‑1 medications are systemic treatments, meaning they work throughout the body rather than targeting a specific “area” like an injectable filler or body-contouring device. They:
- Act on the brain (particularly the hypothalamus) to reduce appetite and increase satiety
- Affect the stomach and intestines by slowing gastric emptying and influencing gut hormones
- Impact pancreatic function, improving insulin secretion and reducing glucagon in people with type 2 diabetes
Because GLP‑1 drugs are taken by injection (usually into the abdomen, thigh, or upper arm) or as an oral tablet (for some formulations), they are used for overall weight reduction, not localized fat loss in a specific body region.
How is GLP‑1 therapy administered and how often?
Most GLP‑1 medications for weight loss are given as a subcutaneous injection (under the skin). Depending on the specific drug:
- Semaglutide for weight management is typically a once‑weekly injection, with the dose slowly increased over several weeks to improve tolerability, as described in clinical dosing guidelines.
- Liraglutide for weight management is usually a once‑daily injection, also titrated up over time.
Injections are usually self-administered at home using a prefilled pen after initial training. Some GLP‑1 drugs for diabetes are available as oral tablets, but not all oral forms are approved for weight loss. Your provider will explain the correct technique, rotation of injection sites, and what to do if you miss a dose.
What results can I expect from GLP‑1 weight‑loss medications?
Results vary, but large clinical trials have shown meaningful weight loss when GLP‑1 therapy is combined with diet and exercise:
- In one major trial of semaglutide for obesity, participants lost an average of about 15% of their body weight over 68 weeks compared with about 2–3% in the placebo group, according to a New England Journal of Medicine study.
- Many patients also see improvements in blood pressure, cholesterol, blood sugar levels, and waist circumference, as reported in meta‑analyses of GLP‑1 agonists.
Weight loss is typically gradual. You may notice decreased appetite within weeks, with more visible weight changes over several months. Long‑term use is often needed to maintain results, alongside sustainable lifestyle changes.
What are the possible side effects and risks of GLP‑1 medications?
Most side effects are gastrointestinal and tend to be mild to moderate, especially during dose escalation. Common side effects include:
- Nausea
- Vomiting
- Diarrhea or constipation
- Abdominal pain or bloating
These are well-documented in FDA safety information and often improve as your body adjusts.
Less common but more serious risks can include:
- Pancreatitis (severe abdominal pain, often radiating to the back)
- Gallbladder problems, including gallstones
- Potential risk of thyroid C‑cell tumors seen in rodent studies; human risk is still being studied, which is why there is a boxed warning in the prescribing information
- Kidney injury, often related to severe dehydration from vomiting or diarrhea
You should contact your provider immediately if you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or symptoms of low blood sugar (especially if you also take insulin or sulfonylureas). GLP‑1 medications are not recommended during pregnancy or breastfeeding, as noted by professional guidelines.
How much do GLP‑1 weight‑loss medications cost in Phoenix?
Costs in Phoenix vary based on:
- The specific medication and dose
- Whether you are using it for diabetes, weight management, or both
- Your insurance coverage and any prior authorization requirements
- Whether you access the drug through a specialty pharmacy, weight‑loss clinic, or primary care provider
Without insurance, GLP‑1 medications can cost several hundred to over a thousand dollars per month, according to pricing data summarized by GoodRx and similar resources. Many manufacturers offer savings programs or copay cards for eligible patients. A consultation with a local provider in Phoenix can help you understand expected monthly costs, coverage options, and any program-based pricing.
Who can administer GLP‑1 in Phoenix?
GLP‑1 medications are prescription drugs and must be ordered and overseen by a licensed healthcare professional. In most U.S. jurisdictions, including Phoenix, the following providers can prescribe and supervise GLP‑1 therapy, in line with state medical board and pharmacy regulations:
- Physicians (MD or DO) – such as primary care doctors, endocrinologists, obesity medicine specialists, and some bariatric surgeons
- Nurse practitioners (NPs) and physician assistants (PAs) – when practicing within their legal scope and under any required collaborative agreements
- Specialists in obesity medicine or endocrinology with additional training in metabolic and weight‑management therapies
Administration is usually self‑injection at home after a clinician provides training. In some weight‑loss clinics in Phoenix, licensed nurses or medical assistants may administer injections on‑site under physician or NP/PA supervision, following state scope‑of‑practice rules and Board of Nursing/Medicine guidelines.
When choosing a provider in Phoenix, look for:
- A valid medical license and, ideally, board certification in a relevant specialty
- Experience managing obesity and metabolic conditions
- A structured monitoring plan (follow‑up visits, lab work, and side‑effect management)
How long do I need to stay on GLP‑1 medication?
GLP‑1 medications are generally intended for long‑term, chronic weight management, similar to how blood pressure or cholesterol medications are used. Studies show that when people stop GLP‑1 therapy, they often regain some or all of the weight lost, as seen in follow‑up analyses of semaglutide trials.
Your provider will:
- Reassess your progress regularly (often every 3–6 months)
- Adjust the dose or switch medications if needed
- Discuss long‑term plans, including whether and how to taper if appropriate
Long‑term success depends heavily on maintaining lifestyle changes (nutrition, physical activity, sleep, and stress management) alongside the medication.
Are GLP‑1 medications safe to combine with other weight‑loss treatments?
It depends on the specific treatments. GLP‑1 medications are sometimes combined with:
- Lifestyle programs (nutrition counseling, exercise plans, behavioral therapy)
- Other metabolic medications in select cases, under specialist supervision
However, combining GLP‑1 drugs with other prescription weight‑loss medications or certain diabetes drugs may increase the risk of side effects like low blood sugar or gastrointestinal issues. Professional obesity medicine guidelines recommend that combination pharmacotherapy be used cautiously and individualized, as discussed in the Obesity Medicine Association’s pharmacologic management guidelines.
Always tell your provider about all medications and supplements you are taking before starting GLP‑1 therapy.
Sources
- New England Journal of Medicine – Once‑Weekly Semaglutide in Adults with Overweight or Obesity
- U.S. Food and Drug Administration – Semaglutide Prescribing Information
- BMJ – Systematic Review and Meta‑analysis of GLP‑1 Receptor Agonists for Weight Loss
- Obesity Medicine Association – Pharmacological Management of Obesity Guidelines
- Federation of State Medical Boards – Guidelines on Scope of Practice
Medically reviewed by Dr. Jessica Anderson, May 10, 2025